Dexcom | DXCM - Biaya Penjualan

Harga Saham
57.55
Perubahan Harian
-1.77 -2.98%
Bulanan
-7.03%
Tahunan
-19.38%
Q2 Perkiraan
60.25




Biaya Penjualan Perubahan Tanggal
Abbott USD 5.3B 380M 2026-03
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
J&J USD 8.07B 103M 2026-03
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Solventum Corp USD 971M 8M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
West Pharmaceutical Services USD 548.5M 47.4M 2026-03
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03